Clinical trials on a new oral antiviral drug, Molnupiravir, from Merck and Ridgeback Biotherapeutics were stopped early because 'the results were so convincing' and...
Chris Woollams Health Watch is an evidence-based, information-only website. We produce short synopses of the latest research in easy-to-understand language. We do NOT answer questions about individual illnesses. However, you can leave comments about the website.
Importantly, people with cancer should go to www.canceractive.com
People with cancer may apply to be 'buddied' by Chris Woollams in a Personal Prescription